Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 15, 2019
[ Mon, Jul 15th 2019
] - WOPRAI
Fri, July 12, 2019
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
[ Fri, Jul 12th 2019
] - WOPRAI
Thu, July 11, 2019
[ Thu, Jul 11th 2019
] - WOPRAI
[ Thu, Jul 11th 2019
] - WOPRAI
[ Thu, Jul 11th 2019
] - WOPRAI
[ Thu, Jul 11th 2019
] - WOPRAI
[ Thu, Jul 11th 2019
] - WOPRAI
[ Thu, Jul 11th 2019
] - WOPRAI
Randall Stanicky Downgraded (AMRX) to Hold and Decreased Target to $6 on, Jul 11th, 2019
Randall Stanicky of RBC Capital, Downgraded "Amneal Pharmaceuticals, Inc." (AMRX) to Hold and Decreased Target from $11 to $6 on, Jul 11th, 2019.
Randall has made no other calls on AMRX in the last 4 months.
There is 1 other peer that has a rating on AMRX. Out of the 1 peers that are also analyzing AMRX, all agrees with Randall's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Gary Nachman of "BMO Capital" Maintained at Hold with Decreased Target to $13 on, Friday, May 10th, 2019
Similar Stocks and Investing Articles
[ Mon, Jul 01st 2019
] - WOPRAI
[ Fri, May 24th 2019
] - WOPRAI
[ Tue, Mar 05th 2019
] - WOPRAI
[ Wed, Oct 03rd 2018
] - WOPRAI
[ Wed, Aug 22nd 2018
] - WOPRAI
[ Tue, Aug 14th 2018
] - WOPRAI
[ Mon, Jul 27th 2015
] - WOPRAI
[ Mon, Jul 27th 2015
] - WOPRAI
[ Thu, Jan 10th 2013
] - WOPRAI